Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

ThermoLife Serves HumanN A Beet Down For Selling Falsely Advertised And Misbranded Products Including SuperBeets, BeetElite, And Neo40


News provided by

ThermoLife International, LLC

Sep 24, 2018, 05:59 ET

Share this article

Share toX

Share this article

Share toX

PHOENIX, Sept. 24, 2018 /PRNewswire/ -- On September 20, 2018, ThermoLife International, LLC filed suit in Arizona Federal District Court against Neogenis Labs, LLC d/b/a HumanN ("HumanN"). ThermoLife is a leading ingredient and technology supplier in the dietary supplement industry. ThermoLife currently controls at least 27 separate patents including 17 patents with more than 450 claims related to novel uses of Nitrates and Amino Acid/nitrate compounds and compositions in Dietary Supplements and food products. ThermoLife is the market leader in nitrate/nitrite technology.

As alleged in ThermoLife's Complaint, HumanN unfairly competes with ThermoLife in the emerging nitrate/nitrite supplementation market by falsely advertising and falsely marking its products with patent numbers that HumanN's products do not practice. HumanN's top-selling SuperBeets, BeetElite, and Neo40 products are heavily marketed on the internet and through television commercials. Through the use of sophisticated internet marketing tools, HumanN's massive internet presence spreads HumanN's lies to anyone who runs a Google search for "Nitric Oxide."

ThermoLife's Complaint highlights in detail HumanN's sophisticated false advertising scheme and deceptive sales tactics. As ThermoLife alleges, HumanN first claims it has the only method to test "if you are N-O [Nitric-Oxide] deficient." Then, after tricking potential customers about the need for HumanN's "Nitric Oxide" supplements, HumanN falsely advertises that it has the "patented" "Nobel Prize winning" cure for Nitric Oxide deficiency; but, HumanN did not win the Nobel Prize and, in fact, in many instances, its products do not practice any patent held by HumanN. 

As alleged in ThermoLife's Complaint, Human's falsely advertised method for testing Nitric Oxide levels is not "patent pending" as claimed in HumanN's advertising (in fact, the patent was denied and abandoned three years ago) and, worse still, it just doesn't work. Independent peer-reviewed clinical testing performed on HumanN's "N-O Indicator Strips" showed there is no correlation between plasma NO2- and salivary NO3. In layman's terms, contrary to HumanN's false advertising, you cannot test whether an individual is "N-O deficient" by simply testing their saliva. As described in ThermoLife's complaint HumanN is fully aware of these facts and they are just blatantly and intentionally lying to consumers to try and fool them into buying HumanN's products.

According to ThermoLife's Complaint, after falsely claiming that consumers can measure whether they are "N-O deficient" using HumanN's falsely advertised "patent pending" Nitric Oxide Indicator Strips, HumanN then falsely claims that it is the only company that can sell Nitric Oxide supplementation technology. HumanN's advertising makes at least four separate and distinct false claims: (1) that HumanN's top-selling SuperBeets, BeetElite, and Neo40 products practice six patents that HumanN exclusively licensed from the University of Texas; (2) that the licensed patents protect "patented Nitric Oxide technology"; (3) that HumanN's research is "Nobel-Prize winning"; and (4) "there is not any product out there, despite the dozens if not hundreds of products, Nitric Oxide products on the market (food or supplement), that do what our technology does."

As ThermoLife's Complaint explains in detail, all of these advertising statements are provably false and HumanN is fully aware that its advertising statements are false. Contrary to HumanN's advertising, HumanN's SuperBeets, BeetElite, and Neo40 products do not actually practice many of the patents that HumanN marks on the products and repeatedly cites in its advertising. In fact, HumanN's SuperBeets and BeetElite products are falsely marked with six separate patents, but the products do not, and have not ever, practiced one single patent claim covered by any of the six patents listed on the products packaging and widely disseminated in HumanN's false advertising.  Also, contrary to HumanN's false advertising, none of patents that HumanN licenses and falsely marks on its products protect "patented Nitric Oxide technology." In fact, HumanN's co-founder, Dr. Nathan Bryan, applied for 19 patent claims pertaining to generating Nitric Oxide. The United States Patent Office declared all 19 claims unpatentable. Thus, contrary to HumanN's massive and willful false advertising campaign, no one, especially HumanN (whose co-founder Dr. Nathan Bryan was specifically denied 19 patent claims related to generating or increasing Nitric Oxide in an individual), holds a patent "for increasing the Nitric Oxide in an individual."

Finally, as ThermoLife's complaint explains because HumanN has intentionally put false and misleading information on the packaging labels of its SuperBeets, BeetElite, and Neo40 products, Federal Law dictates that SuperBeets, BeetElite, and Neo40 are all "misbranded" and therefore prohibited from being sold in interstate commerce. Accordingly, HumanN's intentionally mislabeled and misbranded products should never have been in the marketplace, nor entitled to any sales.

When reached for comment, ThermoLife's founder, Ron Kramer, offered the following statement: "ThermoLife is the market leader in nitrate/nitrite technology. Scientific evidence proves that Nitric Oxide supplements have many great health benefits. While we obviously believe in this technology, we won't mislead consumers about the benefits of our products and the products sold by the many reputable companies that license our technology. On the other hand, HumanN relies on false representation after false representation to deceive consumers into purchasing HumanN's products, instead of products sold and licensed by ThermoLife. ThermoLife holds the patents for the technology in HumanN's products, not HumanN. HumanN is stealing from ThermoLife and intentionally lying to its customers yet I personally gave HumanN every opportunity to do the right thing here before filing suit but to no avail. HumanN's thinks they are above the law and entitled to steal from us and lie to consumers. Now we will let the courts tell HumanN that they cannot be allowed to continue to trick consumers into purchasing HumanN's falsely advertised, misbranded, and infringing products. If there are any legitimate companies out there who want to fill the upcoming void and market HumanN's formulas with a license from ThermoLife, or vastly improve on HumanN's products and take the market share with our new high nitrate beet root extract, please do not hesitate to contact me."

ThermoLife's Complaint seeks an injunction, barring further false advertising by HumanN and actual damages. As a result of HumanN's willfully false advertising, ThermoLife also seeks an order from the court disgorging HumanN's profits and an award of treble damages. Any Judgment against HumanN here could exceed $50,000,000.00.

ThermoLife is represented in the matter by Gregory B. Collins of Kercsmar & Feltus PLLC.

About ThermoLife International:

Founded in 1998, ThermoLife is a world leader in patented ingredients and technology for use in dietary supplements. ThermoLife controls a global patent portfolio of 27 patents spanning more than 15 countries including more than 450 valid and issued claims on the use of nitrates in dietary supplements. ThermoLife collaborates with leading manufacturers in the dietary supplement industry to provide innovative ingredients to help offer superior patent-protected products to end users.

For more information contact [email protected], and see www.ThermoLife.com, www.NO3-T.com, and www.MaxNox.info.

SOURCE ThermoLife International, LLC

Related Links

http://www.ThermoLife.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.